Welcome to QIAGEN!
You can accept or revoke the cookies used on this website at any time with the selection below or by adjusting your cookie settings. For complete details about our cookies, see our Cookie Policy.
QIAGEN Views – Insights from our leadership team
Martí Juanola Falgarona, Associate Director of Medical Affairs
Antimicrobial resistance is an existential threat on par with climate change
AMR is a complex global problem with no single cause – and no single, easy solution. It has far-reaching impacts and curbing it requires collaboration from everyone involved.
Thorsten Harzer, Vice President and Head of Digital Business Solutions
B2B marketing and sales need a 21st-century upgrade
When buyers are shopping for their employers, they want the same seamless experiences they get when they're stocking their own homes. B2B firms that meet that demand will see their sales rise and marketing efficiency skyrocket.
Marc Destito, Vice President and Head of Global Health
Recent Tuberculosis outbreaks in the U.S. are a call to action
A coordinated effort is needed to stop the spread of TB and preventing the next public health emergency.
Roland Sackers, Chief Financial Officer and Managing Director
Forensic investigative genetic genealogy – a huge leap for crime fighting
Forensic Investigative Genetic Genealogy (FIGG) is a quantum leap in forensics, but governments, law enforcement and industry have to realize that the power of FIGG is dependent on public trust.
Roland Sackers, Chief Financial Officer and Managing Director
The Virtuous Circle: Business and Global Health
Companies in the health care industry must become key stakeholders in the virtuous circle, leading in the development of new tools and technologies that are part of our DNA and daily work, and actively working to introduce and scale up their use.
Thierry Bernard, Chief Executive Officer and Managing Director
Pandemics are not done with us
New public health threats are an inevitability. But there's no reason future outbreaks need to be as deadly as COVID.
Angelika Storm, Head of ESG Strategy
Sustainability takes teamwork
Angelika Storm, Head of ESG Strategy and Impact Programs, explains how taking responsibility for environmental, social and governance (ESG) topics drive change around sustainability, whether benefiting the environment or giving access to better health care.
Daniel Schatz, Chief Information Security Officer
Investing in cybersecurity is more important than ever
The last few years have seen major shifts in online threats. All companies – including those in biotech – have to take this seriously and respond.
Thierry Bernard, Chief Executive Officer and Managing Director
We need a huge push to prevent Phi, Rho and Sigma
With Omicron rapidly spreading around the world, we need to learn from our mistakes to prevent emergence of future SARS-CoV-2 variants.
Thierry Bernard, Chief Executive Officer and Managing Director
With focus on the COVID-19 pandemic, the world has taken its eye off TB
Tuberculosis is highly infectious and a global problem that COVID-19 has only made worse. Two legacies of the response to COVID-19 give rise to hope.
Jürgen Schneider, Vice President, Head of Global IP & Licensing
RNA, DNA and the rising cost of IP management
Advances in molecular testing are making patent protection and monitoring ever more difficult. It is time for the sector to reach for new tools.
Thierry Bernard, Chief Executive Officer and Managing Director
A modern healthcare system should invest in diagnostics and testing
The COVID-19 pandemic might yet have an upside: more prevention-driven healthcare.
Stephany Foster, Head of HR
Empower your career
Making a lateral move to a different department or function can allow you to explore a new opportunity without having to start over completely.